DOUBLE-STRANDED RNA COMPOUNDS TO CASP2 AND USES THEREOF

PROBLEM TO BE SOLVED: To treat a patient suffering from or at risk of developing an ocular disease, disorder or injury.SOLUTION: The present invention provides methods of treating a patient suffering from or at risk of developing an ocular disease, disorder or injury, by treatment regimens using a d...

Full description

Saved in:
Bibliographic Details
Main Authors ELENA FEINSTEIN, SHAI ERLICH, RABIA OZDEN, JAMES D THOMPSON
Format Patent
LanguageEnglish
Japanese
Published 28.06.2018
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To treat a patient suffering from or at risk of developing an ocular disease, disorder or injury.SOLUTION: The present invention provides methods of treating a patient suffering from or at risk of developing an ocular disease, disorder or injury, by treatment regimens using a double-stranded RNA compound that down-regulates CASP2 expression, or a pharmaceutically acceptable salt thereof.SELECTED DRAWING: None 【課題】眼の疾患、障害、もしくは傷害に冒されているか、またはそれらを発病する危険性がある患者の治療【解決手段】ＣＡＳＰ２発現を下方制御する二本鎖ＲＮＡ化合物またはその薬学的に許容される塩を使用する治療レジメンにより、眼の疾患、障害、もしくは傷害に冒されているか、またはそれらを発病する危険性がある患者の治療方法を提供する。【選択図】なし
Bibliography:Application Number: JP20170245790